Pages that link to "Q57315836"

The following pages link to Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis (Q57315836):

Displaying 28 items.

• Development of a radioiodinated triazolopyrimidine probe for nuclear medical imaging of fatty acid binding protein 4 (Q28537831) (← links)
• Upregulation of arylsulfatase B in carotid atherosclerosis is associated with symptoms of cerebral embolization (Q33849091) (← links)
• Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke (Q34103370) (← links)
• The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability (Q34775873) (← links)
• Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases (Q35042217) (← links)
• FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway. (Q35060802) (← links)
• Gene expression differences between stroke-associated and asymptomatic carotid plaques (Q35206782) (← links)
• Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis (Q35556624) (← links)
• Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2. (Q35859743) (← links)
• Prediction of ischemic events on the basis of transcriptomic and genomic profiling in patients undergoing carotid endarterectomy (Q36071714) (← links)
• A CYP26B1 polymorphism enhances retinoic acid catabolism and may aggravate atherosclerosis (Q36071717) (← links)
• Fatty acid binding protein 4 expression marks a population of adipocyte progenitors in white and brown adipose tissues (Q36482896) (← links)
• Lessons on conditional gene targeting in mouse adipose tissue (Q36635274) (← links)
• Fatty acid binding protein 4 in circulating leucocytes reflects atherosclerotic lesion progression in Apoe(-/-) mice. (Q37294001) (← links)
• Deficiency of CCAAT/enhancer binding protein-epsilon reduces atherosclerotic lesions in LDLR-/- mice (Q37525150) (← links)
• The utility of collaborative biobanks for cardiovascular research. (Q37928825) (← links)
• Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? (Q38050907) (← links)
• Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators. (Q38059912) (← links)
• Lipid chaperones and metabolic inflammation (Q38908903) (← links)
• Prognostic Utility of Fatty Acid-Binding Protein 4 in Patients with Type 2 Diabetes and Acute Ischemic Stroke (Q47961725) (← links)
• Serum adipocyte fatty acid-binding protein level is associated with arterial stiffness quantified with cardio-ankle vascular index in kidney transplant patients (Q47976365) (← links)
• Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content (Q50089048) (← links)
• α1-Antitrypsin Combines with Plasma Fatty Acids and Induces Angiopoietin-like Protein 4 Expression. (Q51595862) (← links)
• Bone Marrow Cell Transplant From Donors With Cardiovascular Risk Factors Increases the Pro-atherosclerotic Phenotype in the Recipients. (Q53065775) (← links)
• Gene expression signatures, pathways and networks in carotid atherosclerosis (Q57315819) (← links)
• Molecular Dynamics Exploration of Selectivity of Dual Inhibitors 5M7, 65X, and 65Z toward Fatty Acid Binding Proteins 4 and 5 (Q58710194) (← links)
• Associations between Fatty Acid-Binding Protein 4⁻A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus (Q64113748) (← links)
• The association between serum adipocyte fatty acid-binding protein and 3-month disability outcome after aneurysmal subarachnoid hemorrhage (Q89786605) (← links)